Follow-up results of aortic arch cervical debranching performed with the help of a temporary crossover external carotid artery bypass for cerebral protection followed by endovascular thoracic aortic aneurysm repair.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 01 10 2019
revised: 16 12 2019
accepted: 19 12 2019
pubmed: 20 2 2020
medline: 24 11 2020
entrez: 20 2 2020
Statut: ppublish

Résumé

Treating aortic arch aneurysms with conventional open surgical and endovascular stent graft procedures is challenging due to the complex anatomy of the arch and the arteries arising from it that nourish the brain. Cerebral protection is of the utmost importance during the treatment of thoracic aneurysms involving the aortic arch. Between May 2014 and November 2018, 7 patients with thoracic aortic aneurysms involving the aortic arch who underwent aortic arch cervical debranching with our technique were reviewed retrospectively. Because all the patients being considered for conventional surgical aortic arch replacement had serious comorbidities, they were selected to receive hybrid therapy. The mean age of the patients was 71.2 ± 9.4 years. One patient was a woman and 6 patients were men. One patient was given general anaesthesia; the remaining 6 patients had a regional block. A crossover temporary bypass was performed between the external carotid arteries with a 6-mm polytetrafluoroethylene graft for cerebral protection in all patients. Thoracic endovascular aortic repair (TEVAR) was successfully performed in all patients except 1 following debranching. Neurological complications did not occur during the procedures. Patients were followed for a mean of 18.3 ± 4.9 months. One female patient died of exacerbating chronic obstructive pulmonary disease within the first follow-up year. Three other patients died: 1 died of natural causes; 1 died of pneumonia followed by multiorgan failure; and 1 died of myocardial infarction during the mid-term follow-up period. The remaining patients are still being followed and are event free. Endovascular treatment of thoracic aortic diseases involving the aortic arch is facilitated when the aortic arch is debranched. Our cerebral protection method with a temporary crossover bypass between the external carotid arteries provides continuous pulsatile blood flow to the brain; hence, neurologically, it is a reliable procedure. The follow-up results of the patients who underwent aortic arch cervical debranching followed by TEVAR depended on their comorbidities.

Identifiants

pubmed: 32073125
pii: 5740491
doi: 10.1093/icvts/ivaa004
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

724-731

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Didem Melis Oztas (DM)

Department of Cardiovascular Surgery, Bagcilar Training and Research Hospital, Istanbul, Turkey.

Murat Ugurlucan (M)

Department of Cardiovascular Surgery, Istanbul Medipol University, Medical Faculty, Istanbul, Turkey.

Metin Onur Beyaz (MO)

Department of Cardiovascular Surgery, Istanbul Medipol University, Medical Faculty, Istanbul, Turkey.

Mustafa Ozer Ulukan (MO)

Department of Cardiovascular Surgery, Istanbul Medipol University, Medical Faculty, Istanbul, Turkey.

Orcun Unal (O)

Department of Cardiovascular Surgery, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey.

Yilmaz Onal (Y)

Department of Radiology, Fatih Sultan Mehmet State Hospital, Istanbul, Turkey.

Muzaffer Umutlu (M)

Department of Radiology, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey.

Bulent Acunas (B)

Department of Radiology, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey.

Ufuk Alpagut (U)

Department of Cardiovascular Surgery, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH